MANUEL
CAMPOS TOIMIL
Profesor titular de universidad
![Foto de Francisco](/img/nophoto.png)
Francisco
Orallo Cambeiro
Publicaciones en las que colabora con Francisco Orallo Cambeiro (19)
2013
-
Cyclic AMP relaxation of rat aortic smooth muscle is mediated in part by decrease of depletion of intracellular Ca2+ stores and inhibition of capacitative calcium entry
Vascular Pharmacology, Vol. 58, Núm. 1-2, pp. 98-104
2011
-
Trans-resveratrol simultaneously increases cytoplasmic Ca 2+ levels and nitric oxide release in human endothelial cells
Molecular Nutrition and Food Research, Vol. 55, Núm. 8, pp. 1237-1248
2008
-
Short-term or long-term treatments with a phosphodiesterase-4 (PDE4) inhibitor result in opposing agonist-induced Ca 2+ responses in endothelial cells
British Journal of Pharmacology, Vol. 154, Núm. 1, pp. 82-92
2007
-
Effects of (-)-epigallocatechin-3-gallate in Ca2+-permeable non-selective cation channels and voltage-operated Ca2+ channels in vascular smooth muscle cells
Life Sciences, Vol. 80, Núm. 23, pp. 2147-2153
-
Effects of trans- and cis-resveratrol on Ca2+ handling in A7r5 vascular myocytes
European Journal of Pharmacology, Vol. 577, Núm. 1-3, pp. 91-99
2006
-
Study of the mechanisms involved in the vasorelaxation induced by (-)-epigallocatechin-3-gallate in rat aorta
British Journal of Pharmacology, Vol. 147, Núm. 3, pp. 269-280
2005
-
Trans- and cis-resveratrol increase cytoplasmic calcium levels in A7r5 vascular smooth muscle cells
Molecular Nutrition and Food Research, Vol. 49, Núm. 5, pp. 396-404
2004
-
(-)-Epigallocatechin-3-gallate induces contraction of the rat aorta by a calcium influx-dependent mechanism
Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Núm. 5, pp. 496-506
2002
-
Synthesis and vasorelaxant activity of new coumarin and furocoumarin derivatives
Bioorganic and Medicinal Chemistry Letters, Vol. 12, Núm. 5, pp. 783-786
2000
-
Cardiovascular effects of ketanserin on normotensive rats in vivo and in vitro
General Pharmacology: The Vascular System, Vol. 35, Núm. 2, pp. 95-105
-
Synthesis and pharmacological evaluation of 2,3-dihydro-3-oxo-4H- thieno[3,4-e][1,2,4]thiadiazine 1,1-dioxides as voltage-dependent calcium channel blockers
European Journal of Medicinal Chemistry, Vol. 35, Núm. 7-8, pp. 751-759
1998
-
Pyridazine derivatives XIV. Study of the vasorelaxant action of 6-aryl-5-piperidino-3-hydrazinopyridazines in isolated rat thoracic aorta: Comparison with hydralazine
General Pharmacology, Vol. 30, Núm. 2, pp. 201-207
1995
-
Study of the in vivo and in vitro cardiovascular effects of (+)‐glaucine and N‐carbethoxysecoglaucine in rats
British Journal of Pharmacology, Vol. 114, Núm. 7, pp. 1419-1427
1994
-
Effects of hydralazine on contractile responses to α1 and α2-adrenoceptor agonists in isolated rubbed rat aorta
General Pharmacology, Vol. 25, Núm. 1, pp. 165-172
-
Pharmacological study of several effects of hydralazine in the bisected rat vas deferens
European Journal of Pharmacology, Vol. 251, Núm. 1, pp. 83-90
1993
-
Study of the mechanism of the relaxant action of (+)‐glaucine in rat vas deferens
British Journal of Pharmacology, Vol. 110, Núm. 3, pp. 943-948
1992
-
Effect of urethane on hydralazine-induced tachycardia in rats
General Pharmacology, Vol. 23, Núm. 6, pp. 1143-1147
-
Effects of Platelet Activating Factor on Contractions and Ca Influx Induced by Noradrenaline and Potassium in Rat Rubbed and Intact Aorta. Comparison with Its Hypotensive Effect in Anaesthetized Normotensive Rats
Journal of Pharmacy and Pharmacology, Vol. 44, Núm. 4, pp. 344-348
-
Role of the endothelial system in BAY K 8644 enantiomer and nifedipine vasomodulator action in rat aorta
European Journal of Pharmacology, Vol. 221, Núm. 1, pp. 1-8